IJCS | Volume 31, Nº3, May/ June 2018

233 7. Christmann AC, Zanelatto C, Semchechem CC, Novello D, Schiessel DL. Perfil de risco de doenças cardiovasculares e estado nutricional de idosos ativos de Guarapuava – Paraná. UNOPARCient Ciênc Biol Saúde. 2013;15(ESP):349-56. 8. Ho SY, Lam TH, Janus ED; Hong Kong Cardiovascular Risk Factor PrevalenceStudySteeringCommittee.Waisttostatureratioismorestrongly associatedwithcardiovascularriskfactorsthanothersimpleanthropometric indices. Ann Epidemiol. 2003;13(10):683-91. PMID: 14599732. 9. Eickemberg M, Oliveira CC, Roriz AK, Sampaio LR. Bioelectric impedance analysis and its use for nutritional assessments. Rev Nutr Campinas. 2011;24(6):883-93. 10. Guedes DP. Clinical procedures used for analysis of the body composition. Rev bras cineantropom desempenho hum. 2013;15(1):113- 29. doi: http://dx.doi.org/10.5007/1980-0037.2013v15n1p113. 11. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (version 2012). Rev Port Cardiol. 2013;32(7-8):641.e1-641.e61. 12. Associação Brasileira de Nutrologia. Sociedade Brasileira de Nutrição Parenteral e Enteral. Projeto Diretrizes: utilização da bioimpedância para avaliação da massa corpórea. 2009. p. 1-13. 13. The Criteria Committee of the New York Heart Association. Diseases of the heart and blood vessels: Nomenclature and criteria for diagnosis. 6th ed. Boston (Mass): Little Brown; 1964. 14. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign (IL): Human Kinetics Books; 1991. 15. Pitanga FJ, Lessa I. Waist-to-height ratio as a coronary risk predictor among adults. Rev Assoc Med Bras. 2006;52(3):157-61. doi: http://dx. doi.org/10.1590/S0104-42302006000300016. 16. Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991;44(9):955-6. PMID: 1890438. 17. Pitanga FJ, Lessa I. Anthropometric indexes of obesity as an instrument of screening for high coronary risk in adults in the city of Salvador – Bahia. Arq Bras Cardiol. 2005;8(1):26-31. doi: http://dx.doi.org/10.1590/S0066- 782X2005001400006. 18. World Health Organization. (WHO). Obesity preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneve; 1998. 19. Lohman TG. Advances in body composition assessment. Champaign, IL: Human Kinetics Publishers; 1992. 20. Neeland IJ, Gupta S, Ayers CR, Turer AT, Rame JE, Das SR, et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging. 2013;6(5):800-7. doi: 10.1161/ CIRCIMAGING.113.000532. 21. Reis JP, Allen N, Gibbs BB, Gidding SS, Lee JM, Lewis CE, et al. Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: the CARDIA Study. Obesity (Silver Spring). 2014;2(11):2434-40. doi: 10.1002/oby.20865. 22. Moyer VA; U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(5):373-8. doi: 10.7326/0003-4819-157-5-201209040-00475. 23. Borné Y, Hedblad B, Essén B, Engström G. Anthropometric measures in relation to risk of heart failure hospitalization: a Swedish population- based cohort study. Eur J Public Health. 2012;24(2):215-20. doi: 10.1093/ eurpub/cks161. 24. Gastelurrutia P, Lupón J, Domingo M, Ribas N, Noguero M, Martinez C, et al. Usefulness of body mass index to characterize nutritional status in patients with heart failure. Am J Cardiol. 2011;108(8):1166-70. doi: 10.1016/j.amjcard.2011.06.020. 25. Schommer VA, Vogel P, Marcadenti A. Antropometria, composição corporal e prognóstico em pacientes com insuficiência cardíaca. Rev Soc Cardiol Est RG Sul. 2015;28:1-7. 26. Puig T, Ferrero-Gregori A, Roig E, Vazquez R, Gonzalez-Juanatey JR, Pascual-Figal D, et al; REDINSCOR Researchers. Prognostic value of body mass index and waist circumference in patients with chronic heart failure (Spanish REDINSCOR Registry). Rev Esp Cardiol (Engl Ed). 2014;67(2):101-6. doi: 10.1016/j.rec.2013.06.022. 27. Quirino CS, Maranhão RV, Giannini DT. Metabolic syndrome among patients enrolled in a cardiac rehabilitation program. Rev Bras Cardiol. 2014;27(3):180-8. 28. Gomes MN, Maciel MG, Torres RS, Barbosa SN. Relação entre variáveis antropométricas, bioquímicas e hemodinâmicas de pacientes cardiopatas. Int J Cardiovasc Sci. 2015;28(5):392-9. 29. Colombo RC, Aguillar OM, Gallani MC, Gobatto CA. Obesity in patients withmyocardial infarction. Rev Latino-AmEnfermagem. 2003;11(4):461- 7. doi: http://dx.doi.org/10.1590/S0104-11692003000400008. 30. Lobato TA, Torres RS, Guterres AS, Mendes WA, Maciel AP, Santos FC, et al. Anthropometric indicators of obesity among patients with acute myocardial infarction. Rev Bras Cardiol. 2014;27(3):203-12. 31. Mendes WA, Carmin SE, Pinho PM, Silva AC, Machado LM, Araújo MS. Relationship between anthropometric variables and pressure/lipid profiles in adults with chronic non-communicable diseases. Rev Bras Cardiol. 2012;25(3):200-9. 32. Schwenk A, Beisenherz A, Römer K, Kremer G, Salzberger B, Elia M. Phase angle frombioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviraltreatment.AmJClinNutr.2000;72(2):496-501.PMID:10919947. 33. Lee SY, Lee YJ, Yang JH, Kim CM, Choi WS. The Association between phase angle of bioelectrical impedance analysis and survival time in advanced cancer patients: preliminary study. Korean J Fam Med. 2014;35(5):251-6. doi: 10.4082/kjfm.2014.35.5.251. 34. Colín-Ramírez E, Castillo-Martínez L, Orea-Tejeda A, Vázquez-DuránM, Rodríguez AE, Keirns-Davis C. Bioelectrical impedance phase angle as a prognostic marker in chronic heart failure. Nutrition. 2012;28(9):901-5. doi: 10.1016/j.nut.2011.11.033. 35. DoeschC,SuselbeckT,LewelingH,FluechterS,HaghiD,SchoenbergSO,et al.Bioimpedanceanalysisparametersandepicardialadiposetissueassessed bycardiacmagneticresonanceimaginginpatientswithheartfailure.Obesity (Silver Spring). 2010;18(12):2326-32. doi: 10.1038/oby.2010.65. 36. Orea-TejedaA,Sánchez-GonzálezLR,Castillo-MartínezL,Valdespino-Trejo A, Sánchez-SantillánRN, Keirns-Davies C, et al. Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients. Cardiol J. 2010;17(1):42-8. PMID: 20104456. 37. CastilloMartínez L, Colín Ramírez E, Orea Tejeda A, Asensio Lafuente E, Bernal Rosales LP, Rebollar González V, et al. Bioelectrical impedance and strength measurements in patients with heart failure: comparison with functional class. Nutrition. 2007;23(5):412-8. doi: 10.1016/j.nut.2007.02.005. 38. Colín-Ramírez E, Castillo-Martínez L, Orea-Tejeda A, Asensio Lafuente E, Torres Villanueva F, Rebollar González V, et al. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients. Clin Nutr. 2006;25(5):746-57. doi: 10.1016/j.clnu.2006.01.009 39. Silva-Tinoco R, Castillo-Martínez L, Orea-Tejeda A, Orozco-Gutiérrez JJ, Vázquez-Díaz O, Montaño-Hernández P, et al. Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure. Int J Cardiol. 2011;147(2):e24-5. doi: 10.1016/j. ijcard.2009.01.012. Faria et al. Bod composition and heart failure International Journal of Cardiovascular Sciences. 2018;31(3)226-234 Original Article